RESEARCH USE ONLY | Free Shipping Over £140

High Purity

Laboratory Tested

Secure Payments

Bank Transfer & More

Delivery

UK & Europe Wide

SHOP NOW

Tirzepatide 20mg

  • Home
  • Product Details

Tirzepatide 20mg

£180.00

Overview: Tirzepatide is a cutting-edge research tool designed for the study of metabolic disorders, including type 2 diabetes and obesity. This synthetic peptide mimics the actions of both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), making it a dual agonist with potent effects on glucose regulation and weight loss. Available exclusively for research use, Tirzepatide offers a unique opportunity to explore innovative therapeutic avenues in metabolic disease management.

Key Features:

  • Dual Agonist Mechanism: Tirzepatide’s combined activation of GLP-1 and GIP receptors can lead to improved glycemic control and reduced body weight, offering a multifaceted approach to tackle metabolic diseases.
  • Enhanced Stability and Duration: Designed for increased stability and prolonged activity in physiological conditions, Tirzepatide facilitates extended study periods without frequent re-administration, enhancing research efficacy.
  • Versatile Research Applications: Ideal for investigating the pathophysiology of type 2 diabetes, the mechanisms of bariatric surgery, and potential anti-obesity treatments.
  • High Purity Formulation: Provided as a lyophilized powder that ensures high purity and consistency across experimental batches.
  • Composition
  • Packaging
  • Categories
  • Dose
  • Medicine Class
  • : Albendazole
  • : 1 Box Contains 1 Bottle
  • : Antelmintik
  • : Adult & child > 5 Years
  • : Potent Medicine
Category Tag
Buy Now

Secure Payment

High Purity

Fast Delivery

  • Description
  • Additional Information
Overview: Tirzepatide is a cutting-edge research tool designed for the study of metabolic disorders, including type 2 diabetes and obesity. This synthetic peptide mimics the actions of both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), making it a dual agonist with potent effects on glucose regulation and weight loss. Available exclusively for research use, Tirzepatide offers a unique opportunity to explore innovative therapeutic avenues in metabolic disease management. Key Features:
  • Dual Agonist Mechanism: Tirzepatide's combined activation of GLP-1 and GIP receptors can lead to improved glycemic control and reduced body weight, offering a multifaceted approach to tackle metabolic diseases.
  • Enhanced Stability and Duration: Designed for increased stability and prolonged activity in physiological conditions, Tirzepatide facilitates extended study periods without frequent re-administration, enhancing research efficacy.
  • Versatile Research Applications: Ideal for investigating the pathophysiology of type 2 diabetes, the mechanisms of bariatric surgery, and potential anti-obesity treatments.
  • High Purity Formulation: Provided as a lyophilized powder that ensures high purity and consistency across experimental batches.
Applications:
  • Diabetes Mellitus Research: Explore the therapeutic potential and underlying mechanisms of Tirzepatide in glucose homeostasis and insulin secretion.
  • Obesity Studies: Utilize Tirzepatide to study its effects on appetite, energy expenditure, and weight loss.
  • Comparative Pharmacology: Assess the differential impacts of GLP-1 and GIP receptor activation in various metabolic and physiological processes.
  • Development of Combination Therapies: Investigate the synergistic effects of Tirzepatide with other therapeutic agents to enhance efficacy in metabolic disorder management.
Specifications:
  • Composition: Synthetic peptide mimicking GLP-1 and GIP
  • Form: Lyophilized powder for reconstitution
  • Purity: >98% as determined by HPLC
  • Packaging: Available in multiple sizes to support both small-scale and bulk research needs
Permission Information: Tirzepatide is intended for research use only, not for human or veterinary use. Handle with appropriate safety measures in a controlled laboratory setting. Conclusion: Tirzepatide represents a state-of-the-art research tool that enables profound insights into the complex interplay of hormonal pathways involved in metabolism. Its dual agonist capabilities make it a valuable asset for the development of next-generation therapies aimed at combating metabolic diseases such as diabetes and obesity. Unlock the potential of Tirzepatide in your research and pave the way for groundbreaking discoveries and therapeutic innovations.

NOTICE

Disclaimer for Quality Peptide Purchases

By Purchasing From Quality Peptides, you acknowledge and agree that:

Research Use Only: All products are exclusively sold for research purposes. they are not permitted for human use, therapeutic, diagnostic, or clinical application.

Not Medical Products: None of the products listed on our website are medical products, nor should they be marketed or used as such.

Compliance and responsibility: The buyer is responsible for ensuring compliance with all relevant laws and regulations. Quality Peptides holds no liability for misuse of products or any adverse outcomes.

Your purchase signifies your understanding and agreement to these terms.